GIMIC (475A) Q1 FY2027 Earnings Deep Dive: Record-High Profits and the Mid-to-Long-Term Growth Scenario via 'Outdoor Advertising Replacement & AI Integration'

GIMIC Co., Ltd. (Securities Code: 475A) has released its financial results for the first quarter of the fiscal year ending March 2027. In its first Q1 earnings report since listing on the Tokyo Stock Exchange Standard Market, the company achieved record-highs for the first quarter in both revenue and all profit categories , demonstrating a solid performance trajectory.

This report provides a multi-faceted analysis of the company's current performance, key KPIs for its flagship service "Doctor's File," and its mid-to-long-term growth strategy and product roadmap, based on the disclosed earnings presentation materials and transcripts.

---

1. Q1 FY2027 Earnings Highlights: Achieving High Progress Toward Profit Targets

The consolidated results for Q1 FY2027 were exceptionally strong, driven by the steady expansion of the flagship medical information platform, "Doctor's File."

• Revenue : 971 million JPY (+4.9% YoY, 23.6% progress toward full-year plan)
• Operating Profit : 116 million JPY (+2.2% YoY, 38.9% progress toward full-year plan)
• Quarterly Net Profit : 102 million JPY (+32.4% YoY, 44.0% progress toward full-year plan)

Slide Commentary: Background on Progress Rates and Performance Trends

The slide above (Page 4) highlights the key performance metrics for the first quarter. Revenue reached 971 million JPY, showing steady year-on-year growth, while operating profit and quarterly net profit were 116 million JPY and 102 million JPY, respectively. Notably, the company achieved high progress rates against its full-year targets, reaching 38.9% for operating profit and 44.0% for quarterly net profit.

While the revenue progress rate appears to be at 23.6%, the company explains that this is due to the timing of the publication of the medical information magazine "Tayoreru Doctor," which accounts for approximately 20% of total revenue, shifting to the second half of the fiscal year. Performance is tracking according to plan. Despite the high profit progress in Q1, the company has not revised its full-year earnings forecast, as it is entering a phase of full-scale growth strategy execution and investment.

---

2. Key KPI Trends for "Doctor's File": Leveraging the Strength of the Stock-Based Model

GIMIC’s flagship business, "Doctor's File," utilizes a subscription-based (stock-type) model that collects fixed monthly listing fees from medical institutions. The key KPIs disclosed in this report confirm the steady accumulation of its recurring revenue base.

1. Steady Expansion of Customer Base The number of customers reached 7,640 , representing a Compound Annual Growth Rate (CAGR) of 6.4% since Q1 FY2024, driven by continuous new customer acquisition.
2. Increase in Average Revenue Per User (ARPU) The average monthly billing per customer reached 30,500 JPY , an increase of 1,600 JPY over the past three years. The business structure is designed to boost the top line not just through customer growth, but through rising unit prices.
3. Low and Stable Monthly Churn Rate The monthly churn rate has remained in the 0.7%–0.8% range , maintaining a low and stable level below 1.00% , reflecting high customer satisfaction and the essential nature of the service.
4. Annual Recurring Revenue (ARR) Trends ARR (the definitive revenue expected over the next 12 months) reached 2,769 million JPY at the end of Q1, recording an 8.0% CAGR , underscoring the strength of the company's revenue foundation.

---

3. Untapped Markets and Competitive Landscape: Replacing the 110 Billion JPY "Outdoor Advertising" Market

GIMIC targets a market of approximately 170,000 clinics (medical and dental) nationwide. Currently, "Doctor's File" holds a market share of only about 4.4% (7,640 clients) , leaving a vast untapped market.

The company defines its true competitors not as other web-based services, but as the "station signage" and "utility pole advertisements" that remain deeply rooted in the medical industry.

Slide Commentary: The Growth Logic of Shifting Outdoor Ad Budgets to Digital

The slide above (Page 11) is a key conceptual diagram explaining the company's market potential and marketing opportunities. Due to historical advertising regulations under the Medical Care Act, the medical industry has been slow to shift digitally, relying on traditional outdoor advertising. According to the company's "Private Practitioner White Paper 2025," 53.7% of private practitioners nationwide reported spending budgets on outdoor advertising. Assuming an average monthly outdoor ad spend of 100,000 JPY per clinic, there is a potential budget of approximately 110 billion JPY in the outdoor advertising market.

The expansion strategy for "Doctor's File" is not to demand new additional budgets from medical institutions, but to replace outdoor advertising budgets (approx. 100,000 JPY/month), which are difficult to measure and limited in information, with "Doctor's File" (from 35,000 JPY/month), which offers higher cost-effectiveness and the ability to convey detailed information. This clear identification of market opportunity is the core of the company's customer acquisition strategy.

---

4. The "Three Arrows" for Customer Expansion and Branding Initiatives

To expand its customer base, the company is promoting a strategy consisting of "Three Arrows":

• [Arrow 1] Establishing the "Category" and Achieving Top-of-Mind Awareness A strategy to establish the "medical information platform" category itself in society and achieve top-of-mind awareness among patients and doctors. The brand movie "Dr. Yokoi Edition," released in July 2026, surpassed 3.5 million views on YouTube and other platforms within just over a month, achieving an exceptional completion rate of over 40% .
• [Arrow 2] Enhancing Product Features (Deep Matching) By revamping UI/UX and introducing AI, the company aims to provide an experience where "Doctor's File" acts as a consultant rather than just a search tool. The "Deep Matching" feature, which continuously updates doctor dialogue data via AI, is scheduled for launch in the first half of the fiscal year ending March 2028 .
• [Arrow 3] Strengthening Human Capital (Quality and Quantity) Leveraging its increased hiring power post-IPO, the company is building an organizational structure to expand and optimize talent in product development, marketing, and sales.

---

5. Cross-Selling Strategy and ARPU Enhancement Mechanisms

GIMIC aims to maximize ARPU by cross-selling a diverse range of products to the customer base acquired through "Doctor's File."

Currently, approximately 90% of revenue is generated by the flagship "Doctor's File" and the "Tayoreru Doctor" medical information magazine series. However, the company has been developing and introducing peripheral products in the following three areas since before its IPO:

1. HR (Human Resources) Sector To address the severe labor shortage in the medical industry, the company provides the recruitment service "Doctor's File Agent" and the evaluation/management system "Clinico."
2. In-Clinic DX Sector The company offers the patient information sharing app "Medipathy" (compliant with the Ministry of Health, Labour and Welfare guidelines) and the LINE-integrated reservation management system "Regitas" to support clinic operational efficiency.
3. Medical Collaboration Sector The company is expanding initiatives such as the "Medical Collaboration Guide," which connects core hospitals with clinics, and regional medical collaboration events like "Medical Alliance Day," primarily in major metropolitan areas.

---

6. Productivity Improvement and AI Strategy: Operational Reform to Boost Profit Margins

To curb the increase in labor-intensive tasks associated with business expansion and to improve profit margins, the company is rapidly integrating AI into its internal operations.

Slide Commentary: The Growth Loop of AI-Driven Productivity

The slide above (Page 14) illustrates the suite of internal AI tools the company operates and the structural productivity improvements they provide.

Of particular impact is "WA-MIC (Writer AI for GIMIC)," an AI that generates manuscripts from interview recordings. Compared to traditional human-only production processes, it has achieved approximately 3x faster processing speeds . This allows the company to build a system where production costs do not increase proportionally as the number of customers grows.

In addition, the company has developed and introduced internal tools such as the rule-sharing AI "G-INDEX," the sales analysis and proposal generation AI "SYNAC," and the customer-facing automated response AI "Ai-D," creating a growth loop that suppresses headcount growth relative to revenue increases and improves operating profit margins.

---

7. Full-Year Earnings Outlook and Mid-to-Long-Term Vision

FY2027 Full-Year Earnings Forecast

• Revenue : 4,120 million JPY (+4.9% YoY / 17th consecutive year of revenue growth and record-high forecast )
• Operating Profit : 300 million JPY (+2.2% YoY)
• Ordinary Profit : 303 million JPY (+2.3% YoY)
• Net Profit : 232 million JPY (+32.4% YoY)

Mid-to-Long-Term Vision (Target for FY2030)

As the company has just gone public, it is currently refraining from publishing a formal medium-term management plan. However, it has set a quantitative target of "growing into a company capable of generating 900 million JPY in operating profit by the fiscal year ending March 2030, a 3x increase from the current fiscal year."

The company plans to achieve long-term profit growth by diligently executing its basic strategy: "expanding customer numbers (market share)," "increasing unit prices through cross-selling," and "improving production efficiency through AI integration."

---

8. Summary

GIMIC's Q1 FY2027 earnings report confirmed the steady growth of its flagship stock-based business and high progress toward its targets. The company is addressing the clear market opportunity of shifting customers from the massive outdoor advertising market with robust branding and a highly efficient, AI-driven operational structure. Future attention will be focused on the steady execution of its growth initiatives and the resulting mid-to-long-term performance trajectory.